Stock listing

ASX:VFX Visionflex Group Limited Share Price

Home listing (ASX) of Visionflex Group Limited

Follow Visionflex Group Limited into a list and get an email when it puts out news.

Share price · ASX:VFX

$0.04 AUD +0.00 (+8.1%)

Close on Nov 20, 2026

Past year -60.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.037 – $0.04 AUDNov 20, 2026
Volume
133,773 sharesNov 20, 2026
Market cap
$3.47M AUDAt the close on Nov 20, 2026 · price × 86.79M shares outstanding
52-week range
$0.034 – $0.125 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$794 AUDMedian day 5,272 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Visionflex Group Limited logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
ASX:VFX · Home$0.04 AUD+0.003 (+8.1%)133,773$0.037$0.04$0.037$0.037Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:VFX · AUD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.04+0.003+8.1%$0.037$0.04$0.037133,773
$0.037-0.002-5.1%$0.037$0.037$0.037419
$0.0390.000.0%$0.039$0.039$0.0397
$0.0390.000.0%$0.039$0.039$0.0397
$0.0390.000.0%$0.038$0.04$0.03826,007
$0.039-0.001-2.5%$0.04$0.04$0.03923,445
$0.04+0.002+5.3%$0.04$0.04$0.041,858
$0.0380.000.0%$0.038$0.038$0.0381
$0.038+0.001+2.7%$0.037$0.038$0.0374,282
$0.0370.000.0%$0.037$0.037$0.03716,904
$0.0370.000.0%$0.037$0.037$0.03716,904
$0.037+0.001+2.8%$0.037$0.037$0.037410
$0.036-0.001-2.7%$0.037$0.037$0.03620,000
$0.037+0.001+2.8%$0.037$0.037$0.037393
$0.0360.000.0%$0.036$0.036$0.03662,500
$0.036-0.004-10.0%$0.04$0.04$0.03614,699
$0.040.000.0%$0.04$0.04$0.0422,229
$0.040.000.0%$0.04$0.04$0.04792
$0.040.000.0%$0.041$0.041$0.0450,000
$0.040.000.0%$0.041$0.041$0.0458,439
$0.04-0.001-2.4%$0.041$0.041$0.0451,000
$0.041-0.004-8.9%$0.041$0.041$0.0416,261
$0.0450.000.0%$0.045$0.045$0.0454
$0.045-0.01-18.2%$0.045$0.045$0.0451,124
$0.0550.000.0%$0.055$0.055$0.0556
$0.0550.000.0%$0.055$0.055$0.0552
$0.0550.000.0%$0.055$0.055$0.055147
$0.0550.000.0%$0.055$0.055$0.0554
$0.0550.000.0%$0.055$0.055$0.05510,006
$0.055+0.005+10.0%$0.05$0.055$0.0552,794
$0.050.000.0%$0.05$0.051$0.0540,235
$0.05-0.002-3.8%$0.05$0.05$0.056

Splits

1 split · ASX:VFX · every price before a split is adjusted for it

DayRatioWhat
1-for-50Consolidation
Ticker
ASX:VFX
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
ASX
Currency
AUD

What changed lately

Latest news

All Visionflex Group Limited news

Visionflex Group Limited on 6ix

Sector
Health care
Industry
Health care services
News releases
24 in the last 12 months · 156 in all · newest Nov 20, 2026 · oldest 2016
Decks
12 decks · latest Aug 28, 2026

Where Visionflex Group Limited is listed

ListingExchangeCountryCurrency
ASX:VFX · Home listing · This pageASXAustraliaAUD
OTC:VFXGFOTCUnited StatesUSD

Valuation

EV/sales 0.6× against a median of 1.8×: 4th lowest of 8 Health care services companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$2.43M AUD
P/E
Loss
EV/sales
0.6×
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
−21.4%
Operating margin
−51.0%
Net margin
−1.4%
Debt to equity
Negative equity
Beta
No index for this market yet

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Visionflex Group Limited · ASX:VFXUS$2.30MUS$1.61Mn/a0.6×n/an/a−1.4%n/an/a
Modern Mobility Aids, Inc. · OTC:MDRMUS$2.68MUS$2.71Mn/an/an/an/an/an/a-0.74
Healthcare Triangle, Inc. · NASDAQ:HCTIUS$2.63MUS$17.54Mn/a0.6×n/a0.1×−56.4%0.3×2.08
Monsenso A/S · OMXCOP:MONSOUS$2.57MUS$2.69Mn/a2.1×n/a2.6×−81.0%0.1×n/a
Imaging Biometrics Limited · LSE:IBAIUS$2.26MUS$2.43Mn/a2.4×n/a5.6×−50.9%0.6×n/a
Feedback plc · LSE:FDBKUS$2.24M−US$2.77Mn/a−2.4×n/a0.4×−826.2%0.0×n/a
Predilife SA · EURONEXT:ALPREUS$2.16MUS$7.61Mn/a6.2×n/an/a−315.3%n/an/a
RMH Holdings Limited · HKEX:8437US$2.12MUS$2.58Mn/an/an/an/an/an/an/a
INVO Fertility, Inc. · NASDAQ:IVFUS$2.10MUS$3.06Mn/a0.4×n/a0.1×−71.4%0.1×1.62
HealthLynked Corp. · OTC:HLYKUS$2.07MUS$2.05Mn/a1.8×n/an/a−351.6%n/a-0.67
Grey Matters Health Inc · CSE:GREYUS$1.98MUS$1.95Mn/an/an/a1.6×n/a0.0×0.43
Median of the othersUS$2.20MUS$2.63M1.8×1.0×−81.0%0.1×0.43

Team and board

Officers

OfficerRole
Joshua MundeyManaging Director & Chief Executive Officer
James AulsebrookChief FINANCIAL Officer
Michael KafrouniExecutive Director & Chief Operating Officer

Board

DirectorRole
Brook AdcockInterim Chairman
Michael KafrouniExecutive Director & Chief Operating Officer

Events

QuarterResultsShare move
Q2 2025Feb 20, 2025−16.7%
Quarter to Sep 30, 2024Nov 27, 20240.0%
Q4 2024Aug 28, 2024+25.0%
Quarter to Mar 31, 2024May 29, 20240.0%
Q2 2024Feb 25, 2024−20.6%
Quarter to Sep 30, 2023Nov 29, 2023+10.8%
Quarter to Jun 30, 2023Aug 30, 2023−9.8%
Quarter to Mar 31, 2023May 31, 2023−16.4%
Quarter to Dec 31, 2022Mar 1, 2023
Quarter to Sep 30, 2022Nov 30, 2022
All 17 quarters
QuarterResultsShare move
Quarter to Jun 30, 2022Aug 30, 20220.0%
Quarter to Mar 31, 2022Jun 1, 2022+14.1%
Quarter to Dec 31, 2021Feb 25, 2022−17.8%
Quarter to Sep 30, 2021Dec 1, 20210.0%
Quarter to Jun 30, 2021Aug 29, 2021−7.7%
Quarter to Mar 31, 2021Jun 2, 20210.0%
Quarter to Dec 31, 2020Mar 3, 2021+3.5%

Open Events

Decks

DeckKindSlidesDate
FY26 Earnings PresentationEarnings21 slidesAug 28, 2026
FY2025 Earnings PresentationEarnings19 slidesAug 29, 2025
Q4 FY25 Earnings PresentationEarnings13 slidesJul 17, 2025
H1 FY25 Earnings PresentationEarnings20 slidesFeb 21, 2025
Q2 FY25 Earnings PresentationEarnings13 slidesFeb 3, 2025
Investor Presentation (November 2024)Investor deck27 slidesNov 13, 2024
FY2024 Earnings PresentationEarnings30 slidesAug 29, 2024
Investor Presentation (June 2024)Investor deck39 slidesJun 26, 2024
H1 2024 Earnings PresentationEarnings11 slidesFeb 26, 2024
Corporate Update (February 2024)Corporate update31 slidesFeb 8, 2024
All 12 decks
DeckKindSlidesDate
Investor Presentation (January 2022)Investor deck14 slidesJan 25, 2022
Corporate Update (October 2020)Corporate update25 slidesOct 14, 2020

Open Decks

Financials

Annual, in AUD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021
Revenue4.14M4.19M6.65M4.47M4.83M5.38M
Cost of revenue5.02M6.61M2.71M1.06M0
Gross profit-887.1K-2.42M3.94M3.41M4.83M5.38M
Selling, general and administrative5.17M6.75M4.83M5.96M7.65M7.36M
Operating income-2.11M-3.90M-1.64M-3.58M-3.63M-3.30M
Depreciation and amortization55.8K71.2K19.4K26.6K12.9K172.5K
EBITDA-2.06M-3.83M-1.62M-3.55M-3.62M-3.12M
Interest expense157.0K291.9K810.6K308.0K343.4K203.8K
Income before tax-596.2K-3.73M-2.15M-3.90M-6.80M-6.65M
Income tax-538.4K-526.2K-617.5K-616.2K23.7K-179.4K
Net income-57.8K-3.19M-1.83M-3.66M-6.82M-6.47M
Earnings per share, basic-0.00-0.05-0.06-0.13-0.59-0.66

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021
Cash and equivalents1.62M1.89M1.16M1.44M2.01M236.0K
Short-term investments44.1K
Receivables1.02M973.4K369.9K636.4K384.8K592.1K
Inventory233.1K262.6K647.7K1.20M569.1K
Current assets2.99M3.26M2.82M4.08M4.21M1.50M
Property, plant and equipment132.6K51.3K16.8K48.5K
Total assets3.09M3.39M2.88M4.09M4.27M1.55M
Accounts payable160.1K227.9K2.41M3.62M3.14M2.03M
Current liabilities2.86M3.68M5.96M6.59M3.39M2.25M
Long-term debt150.0K1.50M6.83M6.05M4.00M3.25M
Total debt578.0K2.47M13.7M12.1M4.65M3.25M
Total liabilities3.11M5.22M19.8M18.7M8.16M5.54M
Shareholders' equity-14.7K-1.82M-8.11M-6.74M-3.89M-3.99M
Shares outstanding79.3M61.8M28.3M28.7M11.5M9.78M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-1.26M-3.16M-2.80M-3.49M-4.34M
Capital spending-5.77K-28.4K-23.2K-29.9K-21.8K-24.6K-83.5K
Free cash flow-1.27M-3.19M-1.38M-3.68M-2.82M-3.52M-4.43M
Cash from investing-15.6K-29.5K276.8K720.1K-21.8K-24.6K-83.5K
Cash from financing1.02M3.92M798.8K2.36M4.59M1.70M3.71M
Share buybacks-87.8K3.84M04.06M
Change in cash-267.1K728.6K-281.9K-564.3K1.77M-1.82M-718.8K

Open Financials

Filings

FilingDateTypeFiled with
Visionflex Secures University Virtual Care ContractNov 19, 2026Operations updateASX
Results of 2026 Annual General MeetingNov 18, 2026Meeting outcomeASX
Chair and Managing Director/CEO Addresses - 2026 AGMNov 18, 2026Meeting outcomeASX
Notification of cessation of securities - VFXNov 2, 2026FinancingASX
Application for quotation of securities - VFXNov 1, 2026FinancingASX
Q1 FY27 Quarterly Activity ReportOct 30, 2026Other filingsASX
Q1 FY27 Quarterly Activity ReportOct 30, 2026Quarterly reportASX
Q1 FY27 Appendix 4COct 30, 2026Quarterly reportASX
Q1 FY27 Appendix 4COct 30, 2026Quarterly reportASX
Notice of Annual General Meeting/Proxy FormOct 18, 2026Meeting noticeASX
All 156 filings
FilingDateTypeFiled with
Application for quotation of securities - VFXSep 30, 2026FinancingASX
ASX Listing Rule 3.16.4 DisclosureSep 18, 2026Other filingsASX
Application for quotation of securities - VFXSep 17, 2026FinancingASX
FY26 Audited Full Year Results Investor PresentationAug 28, 2026ResultsASX
Appendix 4G and Corporate Governance StatementAug 28, 2026Other filingsASX
Annual Report 2026Aug 28, 2026Annual reportASX
Appendix 4E - FY26Aug 28, 2026ResultsASX
Q4 FY26 Quarterly Activity ReportJul 12, 2026Quarterly reportASX
Visionflex Awarded NSW Health Contract to Supply HardwareJun 25, 2026Acquisition or disposalASX
Q3 FY26 Appendix 4CApr 28, 2026Quarterly reportASX
H1 FY26 Financial ResultsFeb 26, 2026ResultsASX
Appendix 4D and Half-Year ReportFeb 26, 2026Interim reportASX
Appendix 4C - Q2 FY26Jan 22, 2026Quarterly reportASX
Quarterly Activity Report - Q2 FY26Jan 22, 2026Quarterly reportASX
Results of 2025 Annual General MeetingNov 18, 2025Meeting outcomeASX
Appendix 4C - Q1 FY26Oct 30, 2025Quarterly reportASX
Quarterly Activity Report - Q1 FY26Oct 30, 2025Quarterly reportASX
Notice of Annual General Meeting/Proxy FormOct 16, 2025Meeting noticeASX
Conversion of debt into equity at 100% premiumSep 16, 2025FinancingASX
FY25 Audited Full Year ResultsAug 28, 2025ResultsASX
FY25 Results Investor PresentationAug 28, 2025Other filingsASX
Appendix 4E - FY25Aug 28, 2025Annual reportASX
Appendix 4C - Q4 FY25Jul 16, 2025Quarterly reportASX
Quarterly Activity Report - Q4 FY25Jul 16, 2025Quarterly reportASX
Visionflex partners with BHPMay 19, 2025Operations updateASX
Appendix 4C - Q3 FY25Apr 29, 2025Quarterly reportASX
Quarterly Activity Report - Q3 FY25Apr 29, 2025Quarterly reportASX
Visionflex partners with Amplar HealthApr 13, 2025Operations updateASX
Board Restructure AnnouncementFeb 20, 2025Management or board changeASX
H1 FY25 Results Investor PresentationFeb 20, 2025ResultsASX
H1 FY25 Growing Recurring Revenue and Debt ReductionFeb 20, 2025Interim reportASX
Appendix 4D and Half Year ReportFeb 20, 2025Interim reportASX
Amended Appendix 4C - December 2024Feb 6, 2025Quarterly reportASX
Quarterly Activity Report - Q2 FY25Jan 29, 2025Quarterly reportASX
Appendix 4C - Q2 FY25Jan 29, 2025Quarterly reportASX
Investor Presentation - Capital RaiseNov 12, 2024FinancingASX
Visionflex Group Limited raises $1.75m to accelerate growthNov 12, 2024FinancingASX
Trading HaltNov 10, 2024Trading halt or suspensionASX
Quarterly Activity Report - Q1 FY25Oct 25, 2024Quarterly reportASX
Appendix 4C - Q1 FY25Oct 25, 2024Quarterly reportASX
Trading UpdateSep 10, 2024Operations updateASX
FY24 Unaudited Full Year Results Investor PresentationAug 28, 2024ResultsASX
FY24 Unaudited Full Year ResultsAug 28, 2024ResultsASX
Preliminary Final ReportAug 28, 2024ResultsASX
Q4 FY24 Quarterly Activity ReportJul 24, 2024Quarterly reportASX
Appendix 4C - Q4 FY24Jul 24, 2024Quarterly reportASX
Successful Completion and Results of Entitlement OfferJul 24, 2024FinancingASX
ProspectusJun 26, 2024Offer documentASX
Capital RaiseJun 26, 2024FinancingASX
Q3FY24 Quarterly Activities and Appendix 4C Cash Flow ReportApr 29, 2024Quarterly reportASX
Results Presentation - 1H FY24Feb 25, 2024ResultsASX
Appendix 4D - Half Year ReportFeb 25, 2024Interim reportASX
Business Overview and Webinar PresentationFeb 7, 2024Operations updateASX
Quarterly UpdateJan 29, 2024Quarterly reportASX
Appendix 4C - quarterlyJan 29, 2024Quarterly reportASX
Reinstatement to QuotationNov 1, 2023Trading halt or suspensionASX
Consolidation of Capital Motion Withdrawn from Notice of AGMOct 22, 2023Meeting noticeASX
Visionflex receives additional purchase order for $1.1MOct 2, 2023Other filingsASX
Preliminary Full Year ResultsAug 30, 2023ResultsASX
Visionflex receives material purchase order for $1.1MAug 20, 2023Other filingsASX
Reinstatement to Official QuotationApr 26, 2023Trading halt or suspensionASX
Divestment of MyHealth1stApr 21, 2023Acquisition or disposalASX
Completion of PlacementMar 19, 2023FinancingASX
Appointment of CEOJan 25, 2023Management or board changeASX
Response to ASX QueryOct 16, 2022Explanation requestASX
Suspension from Official QuotationOct 11, 2022Trading halt or suspensionASX
CEO ResignationOct 3, 2022Other filingsASX
Sales Update Q3 FY22Apr 12, 2022Other filingsASX
Results of Entitlement OfferFeb 23, 2022FinancingASX
Clarification of Rights Issue - Further Revised TimetableJan 31, 2022FinancingASX
Pause in TradeJan 30, 2022Other filingsASX
Rights Issue - Revised TimetableJan 30, 2022FinancingASX
Investor Presentation - Acquisition of VisionflexJan 24, 2022Acquisition or disposalASX
1st to acquire Visionflex, $2.5m Placement, Rights IssueJan 24, 2022FinancingASX
1st Group signs deal with St John of God Health CareNov 12, 2021Other filingsASX
Entitlement Offer raises $1m to implement FY22 RoadmapOct 3, 2021FinancingASX
1st Group Launches Rights Issue Equity RaisingSep 7, 2021FinancingASX
Quarterly Update (revised)Jul 29, 2021Other filingsASX
Klaus Bartosch re-joins as CEO, Board Renewal completedJun 2, 2021Other filingsASX
Board ChangesMay 25, 2021Other filingsASX
1st Group completes strategic review, with roadmap to FY22May 9, 2021Other filingsASX
Interim CEO AppointmentMar 30, 2021Other filingsASX
Strategic partnership with AfterpayOct 30, 2020Other filingsASX
Business Update Investor PresentationOct 13, 2020Operations updateASX
FY20 Preliminary Full Year ResultsAug 30, 2020ResultsASX
Response to ASX Aware QueryJul 20, 2020Explanation requestASX
Appendix 4C Conversion to New TemplateMay 4, 2020Quarterly reportASX
1st launches Telehealth and TelehealthClinics.com.auApr 14, 2020Other filingsASX
1ST Launches COVID-19 Clinics Directory for AustraliansMar 26, 2020Other filingsASX
1st COVID-19 Market Update - no impactMar 17, 2020Other filingsASX
Appendix 4C - quarterly (corrected)Jan 30, 2020Quarterly reportASX
Placement - Institutional InvestmentDec 11, 2019FinancingASX
StVincentsPriority.com.au service goes liveDec 9, 2019Other filingsASX
Shexie partners to bring MyHealth1st to 3,500 specialistsDec 8, 2019Other filingsASX
1ST signs material agreement with a new major dental groupNov 26, 2019Material contractASX
Response to Appendix 4C QueryNov 6, 2019Quarterly reportASX
FY19 Preliminary Full Year ResultsAug 28, 2019ResultsASX
Quarterly & Full Year UpdateJul 30, 2019Other filingsASX
1st Group signs agreement with Bodycare Workplace SolutionsJul 26, 2019Other filingsASX
$2.6m Placement inc Institutional investment & launch of SPPMay 13, 2019FinancingASX
Agreement with St Vincents Health AustraliaMay 9, 2019Other filingsASX
1st Group enters Psychology MarketApr 11, 2019Other filingsASX
2019 Strategic RoadmapMar 25, 2019Other filingsASX
1st signs agreement with Vetcentric onto PetYeti platformMar 21, 2019Other filingsASX
1st Group signs strategic pilot with MedibankMar 14, 2019Other filingsASX
Response to ASX Appendix 4C QueryFeb 20, 2019Explanation requestASX
ACV guidance for H2 FY19Jan 28, 2019GuidanceASX
Closing of Offer and Notification of UndersubscriptionDec 18, 2018Other filingsASX
Boehringer partners with 1ST to accelerate PetYeti salesNov 29, 2018Other filingsASX
Rights Issue Offer BookletNov 22, 2018FinancingASX
$2.48m Non-Renounceable Rights IssueNov 13, 2018FinancingASX
1ST signs another fast growing large medical centre groupNov 4, 2018Other filingsASX
Change of Registry Address: Automic P/L - Sydney OfficeSep 28, 2018Other filingsASX
Guidance affirmed and extension of convertible loan facilitySep 27, 2018GuidanceASX
FY18 Preliminary Full Year Results AnnouncementAug 30, 2018ResultsASX
1st Group announces maiden guidanceJul 18, 2018GuidanceASX
Quarterly and Full Year UpdateJul 17, 2018Other filingsASX
1ST signs market leading ophthalmology group to MyHealth1stJun 21, 2018Other filingsASX
PETstock signs agreement to deploy PetYeti to 120 locationsJun 19, 2018Other filingsASX
New contract to supply full suite of MyHealth1st productsMay 21, 2018Other filingsASX
First drawdown of Standby convertible loan facilityMar 29, 2018Other filingsASX
MyHealth1st platform extends reach into GP marketFeb 9, 2018Other filingsASX
1ST selected for HCF Catalyst Scaleup Accelerator ProgramFeb 6, 2018Other filingsASX
1ST signs significant advertising contractOct 1, 2017Other filingsASX
Petbarn signs 2 year PetYeti agreement with 1STAug 28, 2017Other filingsASX
1ST secures $2m standby loan facility from major shareholderAug 1, 2017Other filingsASX
1ST - Record Sales in Q4Jul 3, 2017Other filingsASX
1ST Launches MyHealth1st TV & Health GuideJun 20, 2017Other filingsASX
1ST Group Investor BriefingMay 14, 2017Other filingsASX
1ST Group reaches 5 million bookings milestoneFeb 27, 2017Other filingsASX
1ST signs largest subscription deal to dateDec 21, 2016Other filingsASX
1ST accelerates pet care market entry with PetYeti portalDec 11, 2016Other filingsASX
Announces deal with ProVisionNov 22, 2016Other filingsASX
1ST withdraws proposal to acquire OzDocsOnlineNov 18, 2016Acquisition or disposalASX
ASX Market Release - Admission to Official ListNov 7, 2016Other filingsASX
Exclusive distribution partnership with AVAJul 4, 2016Other filingsASX
Placement Share IssueJun 27, 2016FinancingASX
Update on Rights Issue - Fully SubscribedJun 14, 2016FinancingASX
New product launchJun 8, 2016Other filingsASX
1st makes first step to expand into optical marketJun 7, 2016Other filingsASX
1st exceeds 4 million online appointment bookingsJun 6, 2016Other filingsASX
Entitlement Offer BookletMay 12, 2016FinancingASX
Placement and partially underwritten rights issueMay 3, 2016FinancingASX
1st doubles national footprint in 8 monthsMar 13, 2016Other filingsASX
1st signs exclusive deal for 11000 natural therapy providersFeb 11, 2016Other filingsASX
Announcement ClarificationFeb 10, 2016Other filingsASX

Open Filings

Cap table

Built by 6ix from Visionflex Group Limited’s releases

Common shares
86,790,398
Fully diluted
86,790,398

Fully diluted

LineShares
Common shares86,790,398

Share count over time

CountShares
Nov 22, 202686,790,398

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Brook AdcockInterim Chairman · Since at least Nov 5, 2026
James AulsebrookChief FINANCIAL Officer · Since at least Nov 5, 2026
Joshua MundeyManaging Director & Chief Executive Officer · Since at least Nov 5, 2026
Michael KafrouniExecutive Director & Chief Operating Officer · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Visionflex Group Limited.